LSIPR, Gowling WLG team up for biologics survey
Life Sciences IP Review has partnered with international law firm Gowling WLG to launch the Patent Litigation Survey to appraise the patent trends in biologics, biosimilars and next generation therapies.
The survey will help inform an upcoming report, which will be made available to all participants.
Anyone involved in or interested in the fields of biologics, T-cell or gene therapies as either corporate or legal counsel, is invited to take part.
Click here to take the survey.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk